ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.72
0.20%
US Tech 100
20,897.20
-1.35%
S&P 500
5,970.84
-1.11%
US Dollar vs CAD
1.44175
-0.01%
Bitcoin
94,539.08
0.40%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC

  6. Novo Nordisk (PK) (NONOF) Share Price

Novo Nordisk (PK)

Novo Nordisk (PK) (NONOF)

USOTC
88.14
1.51
(1.74%)
Closed December 28 3:00PM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
88.14
Bid
85.73
Ask
90.68
Volume
64,379
87.00 Day's Range 89.77
79.15 52 Week Range 149.55
Market Cap
396.278B
Previous Close
86.6299
Open
88.00
Last Trade
1
@
88.14
Last Trade Time
Financial Volume
US$ 5,636,888
VWAP
87.5579
Average Volume (3m)
55,635
Shares Outstanding
4,496,011,436
Dividend Yield
80.34%
PE Ratio
4.74
Earnings Per Share (EPS)
18.61
Revenue
232.26B
Net Profit
83.68B

About Novo Nordisk (PK)

Novo-Nordisk is the parent company of a group engaged in the development, production and marketing of pharmaceuticals, biological solutions to industrial problems; vitamins, dietary supplements and digestive aids. Co. operates on a worldwide basis in two business segments: Diabetes care: discovery, ... Novo-Nordisk is the parent company of a group engaged in the development, production and marketing of pharmaceuticals, biological solutions to industrial problems; vitamins, dietary supplements and digestive aids. Co. operates on a worldwide basis in two business segments: Diabetes care: discovery, development, manufacturing and marketing of products within the areas of insulin and delivery systems and oral antidiabetic products (OAD). Biopharmaceuticals: discovery, development, manufacturing and marketing of products within the therapy areas haemostasis management (NovoSeven(R) RT), growth hormone therapy, hormone replacement therapy and other products. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.novonordisk.com
Headquarters
Bagsvaerd, Dnk
Founded
-
Novo Nordisk (PK) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker NONOF. The last closing price for Novo Nordisk (PK) was US$86.63. Over the last year, Novo Nordisk (PK) shares have traded in a share price range of US$ 79.15 to US$ 149.55.

Novo Nordisk (PK) currently has 4,496,011,436 shares outstanding. The market capitalization of Novo Nordisk (PK) is US$389.49 billion. Novo Nordisk (PK) has a price to earnings ratio (PE ratio) of 4.74.

Ask ADVFN Intelligence (AI)

NONOF Latest News

More News

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

December 20 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

December 20 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

December 18 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

December 16 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

December 16 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

December 13 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

December 09 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

December 06 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

December 02 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

November 13 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
13.093.6331569664985.0591.179.154726985.69044642CS
4-17.235-16.3558718861105.37511479.1598984107.5298477CS
12-29.61-25.1464968153117.75122.3579.1555635108.82133141CS
26-56.71-39.1508457025144.85147.5579.1543942115.94369218CS
52-17.56-16.6130558184105.7149.5579.1545976122.94940134CS
15633.9362.589928057654.21149.5545.292915898.27218567CS
26059.245205.03547326528.895149.5524.2052426682.09122872CS

NONOF - Frequently Asked Questions (FAQ)

What is the current Novo Nordisk (PK) share price?
The current share price of Novo Nordisk (PK) is US$ 88.14
How many Novo Nordisk (PK) shares are in issue?
Novo Nordisk (PK) has 4,496,011,436 shares in issue
What is the market cap of Novo Nordisk (PK)?
The market capitalisation of Novo Nordisk (PK) is USD 389.49B
What is the 1 year trading range for Novo Nordisk (PK) share price?
Novo Nordisk (PK) has traded in the range of US$ 79.15 to US$ 149.55 during the past year
What is the PE ratio of Novo Nordisk (PK)?
The price to earnings ratio of Novo Nordisk (PK) is 4.74
What is the cash to sales ratio of Novo Nordisk (PK)?
The cash to sales ratio of Novo Nordisk (PK) is 1.71
What is the reporting currency for Novo Nordisk (PK)?
Novo Nordisk (PK) reports financial results in DKK
What is the latest annual turnover for Novo Nordisk (PK)?
The latest annual turnover of Novo Nordisk (PK) is DKK 232.26B
What is the latest annual profit for Novo Nordisk (PK)?
The latest annual profit of Novo Nordisk (PK) is DKK 83.68B
What is the registered address of Novo Nordisk (PK)?
The registered address for Novo Nordisk (PK) is NOVO ALLE, BAGSVAERD, DK-2880
What is the Novo Nordisk (PK) website address?
The website address for Novo Nordisk (PK) is www.novonordisk.com
Which industry sector does Novo Nordisk (PK) operate in?
Novo Nordisk (PK) operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
DTEMFDitem Explorations (CE)
US$ 0.01
(999,900.00%)
1,000
RRMLFRoss River Minerals Inc (CE)
US$ 0.0089
(889,900.00%)
9.95k
FGHFFForte Group Holdings Inc (PK)
US$ 0.3833
(29,384.62%)
432
PRMDPrimeMD Inc (CE)
US$ 0.0002
(19,900.00%)
100
SDCCQSmileDirectClub Inc (CE)
US$ 0.0002
(19,900.00%)
392.07k
CDJMCarnegie Development Inc (CE)
US$ 0.000001
(-100.00%)
2.58k
RAHGFRoan Holdings Group Company Ltd (CE)
US$ 0.000001
(-99.99%)
200
UBMRFUrbanimmersive Inc (CE)
US$ 0.000001
(-99.97%)
1.5k
UNDRUnderSea Recovery Corporation (CE)
US$ 0.000001
(-99.90%)
55k
EICCFE Automotive Inc (CE)
US$ 0.0001
(-99.88%)
5.67k
PHILPHI Group Inc (PK)
US$ 0.0005
(0.00%)
562.38M
GRLFGreen Leaf Innovations Inc (PK)
US$ 0.0001
(0.00%)
284.6M
RDARRaadr Inc (PK)
US$ 0.0016
(-5.88%)
170.08M
HMBLHUMBL Inc (PK)
US$ 0.00085
(6.25%)
153.18M
CGACCode Green Apparel Corp (PK)
US$ 0.0004
(-11.11%)
113.22M

Discussion

View Full Feed
sumbuysumsell sumbuysumsell 9 minutes ago
Promise this is the last one. Version 3. Continued study of ChatGPT question variance. Here, the same version 2 question is revised to ask if a strategic partnership or buyout would be announced at the conference.
Q: What percentage of emerging biotech companies presently moving to market th
JPM
NASDAQ2020 NASDAQ2020 11 minutes ago
https://www.ded.uscourts.gov/sites/ded/files/opinions/20-1362.pdf
ELTP
KVM KVM 12 minutes ago
Maybe because for the past year Veri didn't participate in Ai frenzy and has a year of catching up to do.
VERI
Ranb2khz Ranb2khz 14 minutes ago
Heaven On Earth – Stars Go Dim (Official Lyric Video)

[yt]YhCzzQQNnLA[/yt]

https://www.youtube.com/watch?v=YhCzzQQNnLA






•
Jahvik Jahvik 17 minutes ago
Very nice!!
Feb 1 or sooner we should be hearing more!

Thank you 
HMBL
Golden Cross Golden Cross 21 minutes ago
$ILLR Many Reasons to Like Triller Now...

~ Launch of Triller 5.0 App.
~ Multiple Revenue Streams.
~ New CEO of Triller App is former TikTok executive Sean Kim.
~ TikTok US ban starts 1-19, 2025. Federal court just upheld the law. Huge influx of new users expec
ILLR
ListenToMe ListenToMe 21 minutes ago
PSIL Psycedelic etf - Bottom is in.

BUY BUY BUY RATING!!!
PSIL
sumbuysumsell sumbuysumsell 22 minutes ago
Version 2. Study of ChatGPT question variance. Here, the same question is revised to include that it is s 90 minute presentation and if analyst coverage would be announced at the conference. Vastly different answer………..
Q: What percentage of emerging biotech companies presently moving to mar
JPM
Golden Cross Golden Cross 22 minutes ago
$ILLR Many Reasons to Like Triller Now...

~ Launch of Triller 5.0 App.
~ Multiple Revenue Streams.
~ New CEO of Triller App is former TikTok executive Sean Kim.
~ TikTok US ban starts 1-19, 2025. Federal court just upheld the law. Huge influx of new users expec
ILLR
ListenToMe ListenToMe 28 minutes ago
Don't worry The Beverage is on the way. 💯
PSYCF
10thMountain 10thMountain 29 minutes ago
Anybody here like CRGO?
baltimorebullet baltimorebullet 30 minutes ago
From a weekly investment newsletter I read:

There is a therapy called therapeutic plasma exchange (TPE). Think of it
colloquially as an oil change for your body, getting rid of senescent cells and junk in your body
that are part of the causes of aging and inflammation.
AVXL
PennMilitia PennMilitia 32 minutes ago
New Management arrives in 23 days !

I see 2025 as being one of the best years of this investment. Looking good.
FNMA
trader53 trader53 33 minutes ago
_____________ Money - Our Followers Have Made ________________

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=169030954;

https://investorshub.advfn.com/uimage/uploads/2023/10/14/mxwujEd_Durkee_Picture_is_like_Dennis_OLeary_and_his_girlfriend_picture.jpg
trader53 trader53 36 minutes ago
_____________ Money - Our Followers Have Made ________________


https://investorshub.advfn.com/boards/read_msg.aspx?message_id=165701322

https://investorshub.advfn.com/uicon/155361.png?cb=636360310707230000
benyam benyam 37 minutes ago
i ll see possible price target .10-3
0 c 2-3 month and allmost bucks end of 2025
see ya later higher pps
MONI
capgain capgain 40 minutes ago
Court orders Biden admin to stop selling border wall materials, was 'illegally subverting' laws: Texas AG

https://www.foxnews.com/politics/court-orders-biden-admin-stop-selling-border-wall-materials-illegally-subverting-laws-texas-ag
benyam benyam 40 minutes ago
this is most likely people who speaking deep bs... not everybody but most
MONI
benyam benyam 43 minutes ago
this board start to get so ridiculous c mon everybody cooling down ..... we will get high returns and big that s all folks ..... give company time what s need and don t speak bs.... all of the time
MONI
dsm6 dsm6 46 minutes ago
Back at you Mckvee, hope we are wrong
ALRTF
capgain capgain 49 minutes ago
Jeffrey Steele....medley of songs@ Joe's Pub 7/14/2017

https://www.youtube.com/watch?v=9SIQPMcZyxk
sumbuysumsell sumbuysumsell 56 minutes ago
ChatGPT question and answer regarding JPM conference attendees also have JPM analyst coverage:
Q: What percentage of emerging biotech companies presently moving to market their CNS Alzheimers Disease drug candidates with a recently accepted MAA from the EMA presenting at the 2025 JPM confere
JPM
cojoboy cojoboy 56 minutes ago
Me too...waited on 4's for a while..finally slapped 5's ..and then 4's printed like crazy...just my luck..lol..😂😂😂
CGAC

Your Recent History

USOTC
NONOF
Novo Nordisk (PK)
NASDAQ
GLLIW
Globalink Investment
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads